Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Telangiectatic osteogenic sarcoma.

T Matsuno, K K Unni, R A McLeod

    Cancer
    |December 1, 1976
    PubMed
    Summary

    Telangiectatic osteogenic sarcoma is a rare bone cancer. This study found it has a poor prognosis, with most patients dying from metastatic disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Chondroblastoma.

    Orthopedics·2014
    Same author

    Mayo clinic tumor rounds.

    Orthopedics·2014
    Same author

    Mayo clinic tumor rounds.

    Orthopedics·2014
    Same author

    Malignant lymphoma of bone.

    Orthopedics·2014
    Same author

    Chordoma of the sacrum.

    Orthopedics·2014
    Same author

    Malignant giant cell tumor of bone.

    Orthopedics·2014

    Area of Science:

    • Oncology
    • Orthopedic Surgery
    • Pathology

    Background:

    • Osteogenic sarcoma is a primary malignant bone tumor.
    • Telangiectatic osteogenic sarcoma is a rare subtype with distinct clinical and radiographic features.

    Purpose of the Study:

    • To describe the clinical, radiographic, and histologic features of telangiectatic osteogenic sarcoma.
    • To evaluate the prognosis and outcomes of patients with telangiectatic osteogenic sarcoma.

    Main Methods:

    • Retrospective review of 25 cases of telangiectatic osteogenic sarcoma diagnosed at the Mayo Clinic.
    • Analysis of patient demographics, lesion location, radiographic findings, gross and histologic features, and treatment outcomes.

    Main Results:

    • The study identified 25 cases of telangiectatic osteogenic sarcoma among 1,999 osteogenic sarcomas.
    • Lesions were typically central, lytic, and located in the distal femur or proximal humerus.
    • High mortality rate observed, with 23 of 25 patients dying from metastatic disease.

    Conclusions:

    • Telangiectatic osteogenic sarcoma has a significantly poorer prognosis compared to conventional osteogenic sarcoma.
    • Early diagnosis and aggressive treatment are crucial for improving patient outcomes.
    • Further research is needed to understand the unique biology and develop targeted therapies for this subtype.

    Related Experiment Videos